Lifetime Brands

LCUT · NASDAQ

$8.20+$0.17 (+2.12%)TodayMarket closed · Oct 20, 7:35 PM ET

Prev close $8.03

LCUT analyst rating

BuyConsensus of 2 analysts over the last 12 months. 50% rate it a buy.

Strong buy0
Buy1
Hold1
Underperform0
Sell0

12-month price target · 5 analysts

Average $10.88 (+32.7% upside)

Low: $7.07
Now: $8.20
High: $13.65

Upgrades and downgrades

The latest rating actions, newest first

LCUT analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Canaccord Genuity	Jul 22, 2026	Maintains	Hold	$6.00 → $7.00	49%
Roth Capital	Jul 13, 2026	Maintains	Buy	$8.00 → $10.00	39%
Canaccord Genuity	May 11, 2026	Maintains	Hold	$5.00 → $6.00	49%
Canaccord Genuity	Apr 16, 2026	Maintains	Hold	$3.50 → $5.00	49%
Canaccord Genuity	Mar 13, 2026	Maintains	Hold	$3.50	49%
Canaccord Genuity	Jan 26, 2026	Downgrade	Buy → Hold	$4.00 → $3.50	49%
Canaccord Genuity	Nov 7, 2025	Maintains	Buy	$5.00 → $4.00	49%

The case for and against

Updated May 30, 2025

Bull case

Lifetime Brands Inc. has demonstrated resilience in the face of fluctuating market conditions, notably achieving positive international organic sales growth of 8.4% in 3Q24, driven by strategic distribution gains in larger retail channels. The company reported strong free cash flow of $53 million in 2023 while simultaneously reducing its debt by $45 million, indicating effective financial management and a solid balance sheet. Furthermore, the positive outlook is reinforced by growth in e-commerce sales, which accounted for nearly 19% of total sales, alongside the anticipated benefits from new product lines and increased production efficiencies in Mexico.

Bear case

Lifetime Brands Inc. has reported disappointing financial results for the third quarter of 2024, with EBITDA declining by 14% to $16.9 million, significantly below consensus expectations of $21.8 million. The company's sales guidance for 2024 has been lowered by $20 million and reflects a projected growth range of only -1% to +2%, while actual sales have consistently underperformed, showing negative organic growth in all but one of the past eight years, excluding the COVID-19 pandemic. Factors contributing to the negative outlook include weak point-of-sale trends, ongoing challenges in European profitability, material exposure to tariffs, and high leverage associated with planned capital expenditures.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.